Skip to main content
Caplight Logo









Innovative Diagnostics

Innovative Diagnostics

Private
GrabelsHealthcare & Life Scienceshttps://www.innovative-diagnostics.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$10.16M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Innovative Diagnostics is a life sciences company that specializes in the development, production, and commercialization of serological and molecular biology tests for the diagnosis of zoonotic and veterinary diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

veterinary diagnosticszoonotic disease testingELISAPCRanimal healthdiagnostic kitsOne Healthmolecular diagnosticsserological testinglab reagentsvet lab suppliesdisease eradicationvaccination monitoringrapid diagnostic testsanimal disease control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innovative Diagnostics Comparables

Compare Innovative Diagnostics with similar companies based on industry and business-model similarity.

Innovative Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VMRD, Inc.
81%
MEGACOR Diagnostik GmbH
80%
Vimian Group
78%

Innovative Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
Series AJul 1, 2024
SeedMar 22, 2024
M&ASep 7, 2018

Key People

Founding team and executive leadership

Philippe Pourquier

Chief Executive Officer

Executive Team

Innovative Diagnostics Investors

Notable investors and investment history

Innovative Diagnostics investors
InvestorRounds
PACE (Pathways to Antimicrobial Clinical Efficacy)Grant
TPG CapitalM&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 32% MoM.

  • Jul 28, 2026

    Monthly visitors increased 73% MoM.

Innovative Diagnostics Filings

Explore SEC and related filing metadata, where available.

Innovative Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Innovative Diagnostics's valuation, stock price, and market status.

Is Innovative Diagnostics a public or private company?

Innovative Diagnostics is a private company.

What is the current stock price of Innovative Diagnostics?

Innovative Diagnostics is a private company with no public stock price. Caplight tracks Innovative Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Innovative Diagnostics worth (valuation)?

Valuation information for Innovative Diagnostics is not publicly available.

Can I buy Innovative Diagnostics stock?

Innovative Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Innovative Diagnostics's last funding round?

Innovative Diagnostics's most recent funding round was Grant on November 19, 2025.

Who are the main investors in Innovative Diagnostics?

Key investors in Innovative Diagnostics include TPG Capital.

Will Innovative Diagnostics IPO soon?

No public IPO plans have been announced for Innovative Diagnostics.

How can I track Innovative Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Innovative Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrabels
Employee Range149
Year Founded2004
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?